Graduate student and trainee researchers and their mentors in the Department of Pharmacology and Toxicology received positive feedback on in-depth studies they presented at the 2016 Behavior, Biology and Chemistry: Translational Research in Addiction meeting.
John M. Sullivan, MD, PhD, associate professor of ophthalmology, has received three grants totaling over $2.5 million to continue research that could lead to gene therapies for hereditary retinal and macular degenerations.
Aspiring physician-scientists showcased 38 original research projects at the 2016 Medical Student Research Forum. The displays showed work they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
Ninety-five student-scientists presented projects during the 2015 Buffalo Summer Research Day, an interdisciplinary forum marking the culmination of their summer research in Buffalo.
Two expert reviewers for the global literature review service F1000Prime have recommended a University at Buffalo paper identifying molecular mechanisms affected by the local anesthetic bupivacaine.
The Graduate School has recognized Anthony A. Campagnari, PhD ’84, professor of microbiology and immunology and medicine, with an Excellence in Graduate Student Mentoring Award.
University at Buffalo researchers are the first to identify solifenacin as a drug target to promote stem cell therapy for myelin-based disease, such as multiple sclerosis.
An international team led by Jonathan F. Lovell, PhD, assistant professor of biomedical engineering, has created a nanoparticle that may pave the way for “hypermodal” imaging — the ability to merge results from six different imaging modes using one contrast agent.
University at Buffalo researchers have designed a biomedical device that could make chemotherapy more efficient, reduce its side effects and improve how doctors treat some of the most deadly forms of cancer.
With the goal of improving chemotherapy, Jennifer A. Surtees, PhD, associate professor of biochemistry, will study what makes cancer cells sensitive or resistant to different DNA-damaging drugs.
Using mechanical stress, scientists at the University at Buffalo and colleagues have turned normal cells into ‘stem-like’ cells, suggesting a possible safe, new way to produce stem cells.
University at Buffalo research on acetylcholine receptors (AChR) will help pharmacologists better understand how drugs work and could help make “receptor engineering” a reality.
A University at Buffalo biochemist led the first study to identify the liver kinase B1 (LKB1) pathway as a possible therapeutic target for neuropathies, including diabetic neuropathy.
A drug developed by University at Buffalo scientists from a small protein found in spider venom is moving forward as a promising treatment for Duchenne muscular dystrophy, a fatal genetic disease affecting boys.
University at Buffalo researchers have helped discover a sleep-promoting circuit in the brainstem, revealing how we fall into deep sleep — findings that may lead to new therapies for sleep disorders.
Applicants are required to apply to the PhD Program in Biomedical Sciences through Graduate School Application Manager, UB's electronic application system.
